The My EpiPen Savings Card

  • The My EpiPen Savings Card® can reduce the out-of-pocket cost for EpiPen by $300 for eligible patients
  • Savings card valid for up to 3 EpiPen 2-Pak® (epinephrine injection, USP) cartons (six EpiPen® Auto-Injectors) per prescription fill—so patients have immediate access to an EpiPen 2-Pak® in multiple locations
  • Patients can download the My EpiPen Savings Card® here

The MyGenericEAI Savings Card

  • The MyGenericEAI Savings Card can reduce the out-of-pocket cost of Mylan’s authorized generic for EpiPen® by $25 for eligible patients*.
  • Savings card valid for up to three Epinephrine Injection, USP Auto-Injector two-pack cartons (six auto-injectors) per prescription fill—so patients have immediate access in multiple locations.
  • Patients can download the MyGenericEAI Savings Card here

*Certain restrictions apply. See full Terms and Conditions for My EpiPen Savings Card® here and MyGenericEAI Savings Card here. These offers are not valid for patients covered by Medicare, Medicaid or any other federal or state funded healthcare program or where prohibited by law. Mylan Specialty L.P. reserves the right to amend or end this program at any time without notice.

Take the right steps to put EpiPen® Auto-Injectors in their hands

Learn more about the right steps to prescribing EpiPen® (epinephrine injection, USP) Auto-Injectors for your patients.

Share This Site


Mylan offers Access and Savings Programs for eligible patients. See Terms and Conditions.

There’s only one recommended first line treatment for anaphylaxis.

More Important Safety Information

EpiPen® (epinephrine injection, USP) 0.3 mg and EpiPen Jr® (epinephrine injection, USP) 0.15 mg Auto-Injectors are intended for immediate administration as emergency supportive therapy only and are not intended as a substitute for immediate medical or hospital care. In conjunction with the administration of epinephrine, the patient should seek immediate medical or hospital care. More than two sequential doses of epinephrine should only be administered under direct medical supervision.

EpiPen® and EpiPen Jr® should only be injected into the anterolateral aspect of the thigh. Do not inject intravenously, into buttock, or into digits, hands, or feet. Instruct caregivers to hold the leg of young children firmly in place and limit movement prior to and during injection to minimize risk of injection-related injury.

Rare cases of serious skin and soft tissue infections have been reported following epinephrine injection. Advise patients to seek medical care if they develop symptoms of infection such as persistent redness, warmth, swelling, or tenderness at the injection site.

Epinephrine should be used with caution in patients with heart disease, and in patients who are on drugs that may sensitize the heart to arrhythmias, because it may precipitate or aggravate angina pectoris and produce ventricular arrhythmias. Arrhythmias, including fatal ventricular fibrillation, have been reported, particularly in patients with underlying cardiac disease or taking cardiac glycosides, diuretics, or anti-arrhythmics.

Patients with certain medical conditions or who take certain medications for allergies, depression, thyroid disorders, diabetes, and hypertension, may be at greater risk for adverse reactions. Common adverse reactions to epinephrine include anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties.


EpiPen® and EpiPen Jr® Auto-Injectors are indicated in the emergency treatment of Type I allergic reactions, including anaphylaxis, to allergens, idiopathic and exercise-induced anaphylaxis, and in patients with a history or increased risk of anaphylactic reactions. Selection of the appropriate dosage strength is determined according to body weight.

Please see the full Prescribing Information and Patient Information.


  1. Boyce JA, Assa’ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6)(suppl):S1-S58
  2. Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010;125(2)(suppl 2):S161-S181.
  3. EpiPen [prescribing & patient information]. Morgantown, WV: Mylan Specialty L.P.; 8/2018.
  4. Epinephrine Injection, USP [prescribing & patient information]. Morgantown, WV: Mylan Specialty L.P.; 8/2018.
EpiPen® & EpiPen Jr® (epinephrine injection, USP) Auto-Injectors 0.3/0.15mg

You are now leaving Mylan Specialty's website.

The website you are about to access is not owned or controlled by Mylan Specialty.



This site is intended for US healthcare professionals.

If you are a patient, please check out our site for patients.